Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
- Status
- COMPLETED
- Phase
- PHASE4
Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- Status
- RECRUITING
- Phase
- PHASE2
The Dublin Zepatier Study
- Status
- TERMINATED
- Phase
- PHASE4
Lung Cancer Early Molecular Assessment Trial
- Status
- UNKNOWN
- Phase
- N/A
Pembrolizumab in HNSCC With Residual Disease After Radiation
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular Block
- Status
- TERMINATED
- Phase
- PHASE1
Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab In Central Nervous System Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2